Skip to Content

Ebos Group Ltd ADR EBOSY

Morningstar Rating
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

EBOSY is trading at a 352% premium.
Price
$31.56
Fair Value
$72.50
Uncertainty
Medium
1-Star Price
$31.42
5-Star Price
$45.50
Economic Moat
Xgkxdw
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if EBOSY is a good fit for your portfolio.

Trading Information

Previous Close Price
Day Range
52-Week Range
Bid/Ask
$40.71 / $47.46
Market Cap
Volume/Avg
/

Key Statistics

Price/Earnings (Normalized)
27.02
Price/Sales
0.46
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Ebos is the largest pharmaceutical wholesaler and distributor across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 60% and 30% of revenue, respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government’s Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low-single-digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.
Sector
Healthcare
Industry
Medical Distribution
Stock Style Box
Mid Core
Total Number of Employees
5,000

Competitors

Valuation

Metric
EBOSY
MCK
CAH
Price/Earnings (Normalized)
27.0220.0313.38
Price/Book Value
2.83
Price/Sales
0.460.240.11
Price/Cash Flow
23.7716.829.93
Price/Earnings
EBOSY
MCK
CAH

Financial Strength

Metric
EBOSY
MCK
CAH
Quick Ratio
0.710.500.43
Current Ratio
1.240.920.98
Interest Coverage
5.0515.5718.37
Quick Ratio
EBOSY
MCK
CAH

Profitability

Metric
EBOSY
MCK
CAH
Return on Assets (Normalized)
4.19%5.63%4.01%
Return on Equity (Normalized)
11.55%
Return on Invested Capital (Normalized)
8.77%64.13%97.71%
Return on Assets
EBOSY
MCK
CAH
See how this stock stacks up to its competitors with Morningstar Investor

Medical Distribution Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
MCK
McKesson CorpSsqsytdTlvnhly$71.4 Bil
COR
Cencora IncVzgkvvmpqWsgpykm$43.1 Bil
CAH
Cardinal Health IncBzrjqpxtBmrlcm$23.1 Bil
SHTDY
Sinopharm Group Co Ltd ADRZkrxx$8.7 Bil
SHPMF
Shanghai Pharmaceuticals Holding Co Ltd Class HYnryg$8.6 Bil
SHTDF
Sinopharm Group Co LtdXybgdp$8.6 Bil
SHPMY
Shanghai Pharmaceuticals Holding Co Ltd ADR repr Class HNfxvmh$8.4 Bil
AMFPF
Amplifon SpA Az nom Post FrazionamentoTqrjn$8.3 Bil
MAHLY
Medipal Holdings Corp ADRBvkp$3.0 Bil
MEPDF
Medipal Holdings CorpQdpm$3.0 Bil

Sponsor Center